Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †.

Autor: Rinella ME; University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA., Castro Narro GE; Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico.; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile., Krag A; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; European Association for the Study of the Liver (EASL), Geneva, Switzerland., Terrault N; Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; American Association for the Study of Liver Diseases (AASLD), Alexandria, USA., Newsome PN; National Institute for Health Research, Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK.; Centre for Liver & Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Jazyk: angličtina
Zdroj: Hepatology (Baltimore, Md.) [Hepatology] 2024 Feb 01; Vol. 79 (2), pp. E16-E17. Date of Electronic Publication: 2023 Dec 19.
DOI: 10.1097/HEP.0000000000000705
Databáze: MEDLINE